Girish Ratnaparkhi

Dr. Girish Ratnaparkhi

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2001 in Journal of Biological Chemistry
Verified
Journal Article
Open access
GRGirish Ratnaparkhi
Girish Ratnaparkhi
RVRaghavan Varadarajan
Raghavan Varadarajan
Osmolytes stabilize proteins to thermal and chemical denaturation. We have studied the effects of the osmolytes sarcosine, betaine, trimethylamine-N-oxide, and taurine on the structure and stability of the protein.peptide complex RNase S using x-ray crystallography and titration calorimetry, respectively. The largest degree of stabilization is achieved with 6 m sarcosine, which increases the denaturation temperatures of RNase S and S pro by 24.6 and 17.4 degrees C, respectively, at pH 5 and protects both proteins against tryptic cleavage. Four crystal structures of RNase S in the presence of different osmolytes do not offer any evidence for osmolyte binding to the folded state of the protein or any perturbation in the water structure surrounding the protein. The degree of stabilization in 6 m sarcosine increases with temperature, ranging from -0.52 kcal mol(-1) at 20 degrees C to -5.4 kcal mol(-1) at 60 degrees C. The data support the thesis that osmolytes that stabilize proteins, do so by perturbing unfolded states, which change conformation to a compact, folding competent state in the presence of osmolyte. The increased stabilization thus results from a decrease in conformational entropy of the unfolded state.


23 April 1998 in Biochemistry
Verified
Journal Article
Closed access
GRGirish Ratnaparkhi
Girish Ratnaparkhi
SRS. Ramachandran
S. Ramachandran
JUJayant B. Udgaonkar
Jayant B. Udgaonkar
RVR. Varadarajan
R. Varadarajan

7 April 2021 in Biochemistry
Verified
Journal Article
Closed access
KKKundan Kumar
Kundan Kumar
Amol Balasaheb MhetreAmol Balasaheb Mhetre
Amol Balasaheb Mhetre
GRGirish Ratnaparkhi
Girish Ratnaparkhi
SKSiddhesh S. Kamat
Siddhesh S. Kamat

31 October 2014 in Biology Open
Verified
Journal Article
Open access
PDF file
SDSenthilkumar Deivasigamani
Senthilkumar Deivasigamani
HVHemant Kumar Verma
Hemant Kumar Verma
RURyu Ueda
Ryu Ueda
ARAnuradha Ratnaparkhi
Anuradha Ratnaparkhi
GRGirish Ratnaparkhi
Girish Ratnaparkhi
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by selective death of motor neurons. In 5–10% of the familial cases, the disease is inherited because of mutations. One such mutation, P56S, was identified in human VAPB that behaves in a dominant negative manner, sequestering wild type protein into cytoplasmic inclusions. We have conducted a reverse genetic screen to identify interactors of Drosophila VAPB. We screened 2635 genes and identified 103 interactors, of which 45 were enhancers and 58 were suppressors of VAPB function. Interestingly, the screen identified known ALS loci – TBPH, alsin2 and SOD1. Also identified were genes involved in cellular energetics and homeostasis which were used to build a gene regulatory network of VAPB modifiers. One key modifier identified was Tor, whose knockdown reversed the large bouton phenotype associated with VAP(P58S) expression in neurons. A similar reversal was seen by over-expressing Tuberous Sclerosis Complex (Tsc1,2) that negatively regulates TOR signaling as also by reduction of S6K activity. In comparison, the small bouton phenotype associated with VAP(wt) expression was reversed with Tsc1 knock down as well as S6K-CA expression. Tor therefore interacts with both VAP(wt) and VAP(P58S), but in a contrasting manner. Reversal of VAP(P58S) bouton phenotypes in larvae fed with the TOR inhibitor Rapamycin suggests upregulation of TOR signaling in response to VAP(P58S) expression. The VAPB network and further mechanistic understanding of interactions with key pathways, such as the TOR cassette, will pave the way for a better understanding of the mechanisms of onset and progression of motor neuron disease.

1 July 1994 in Biochemistry
Verified
Journal Article
Closed access
JTJames Thomson
James Thomson
GRGirish Ratnaparkhi
Girish Ratnaparkhi
RVRaghavan Varadarajan
Raghavan Varadarajan
JSJulian M. Sturtevant
Julian M. Sturtevant
FRFrederic M. Richards
Frederic M. Richards